Apogee Therapeutics is widely known for its proprietary antibody engineering expertise, which focuses on optimizing the half-life and potency of biological treatments. By targeting well-established disease pathways with advanced molecular designs, the company aims to deliver significantly extended dosing intervals—such as infrequent maintenance schedules—for patients suffering from chronic dermatological, respiratory, and immunological disorders.